Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.37 and traded as low as $0.22. Arch Therapeutics shares last traded at $0.27, with a volume of 3,757 shares traded.
Arch Therapeutics Stock Performance
The firm has a 50-day simple moving average of $0.20 and a two-hundred day simple moving average of $0.37.
Arch Therapeutics Company Profile
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Further Reading
- Five stocks we like better than Arch Therapeutics
- How to Calculate Stock Profit
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Most active stocks: Dollar volume vs share volume
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Pros And Cons Of Monthly Dividend Stocks
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
